AQR Arbitrage’s Medicines Co MDCO Stock Holding History

AQR Arbitrage’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,528,417	Closed	-$130M	–	643
2019 Q4	$130M	Buy	+1,528,417	New	+$102M	2.19%	8
2019 Q1	–	Sell	-80,854	Closed	-$1.55M	–	597
2018 Q4	$1.55M	Buy	+80,854	New	+$1.88M	0.02%	235

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

AQR Arbitrage's MDCO Position: Q1 2020 in Review

AQR Arbitrage sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 1,528,417 shares — an estimated $130M sold.

AQR Arbitrage first reported a position in MDCO in Q4 2018 and held it in 2 quarters. The position peaked at $130M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

AQR Arbitrage reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
AQR Arbitrage sold 1,528,417 Medicines Co shares in Q1 2020, an estimated $130M.
AQR Arbitrage first reported a position in Medicines Co in Q4 2018 and held it in 2 quarters.
AQR Arbitrage's Medicines Co position peaked at $130M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on AQR Arbitrage's 13F filing for Q1 2020, filed 15 May 2020.